INTELLECTUAL ABILITY IN THE DUCHENNE
MUSCULAR DYSTROPHY AND DYSTROPHIN GENE
MUTATION LOCATION
Milic Rasic V1,2,*, Vojinovic D1, Pesovic J3, Mijalkovic G1, Lukic V1, Mladenovic J1,
Kosac A1, Novakovic I4, Maksimovic N4, Romac S3, Todorovic S1, Savic Pavicevic D3
*Corresponding Author: Vedrana Milic Rasic, M.D., Ph.D., Clinic for Neurology and Psychiatry for Children
and Youth, Dr. Subotica 6A, 11000 Belgrade, Serbia. Tel: +381-11-265-8355. Fax: +381-11-264-5064. E-mail:
vedrana.milic.npk@gmail.com
page: 25
|
|
REFERENCES
1. Emery A, Muntoni F. Duchenne muscular dystrophy.
3rd ed. New York, NY: Oxford University
Press, 2003.
2. Cotton S, Voudouris NJ, Greenwood KM. Intelligence
and Duchenne muscular dystrophy:
Full-scale, verbal, and performance intelligence
quotients. Dev Med Child Neurol. 2001; 43(7):
497-501.
3. Cotton S, Voudouris N, Douglas J. Key findings
from a meta-analytical study on intellectual
functions in Duchenne muscular dystrophy. J
Intell Disabil Res. 2000; 44(3-4): 248-248.
4. Koenig M, Hoffman EP, Bertelson CJ, Monaco
AP, Feener C, Kunkel LM. Complete cloning
of the Duchenne muscular dystrophy (DMD)
cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.
Cell. 1987; 50(3): 509-517.
5. Monaco AP, Bertelson CJ, Liechti-Gallati S,
Moser H, Kunkel LM. An explanation for the
phenotypic differences between patients bearing
partial deletions of the DMD locus. Genomics.
1988; 2(1): 90-95.
6. Lidov HG, Byers TJ, Watkins SC, Kunkel LM.
Localization of dystrophin to postsynaptic regions
of central nervous system cortical neurons.
Nature. 1990; 348(6303): 725-728.
7. Tokarz SA, Duncan NM, Rash SM, Sadeghi A,
Dewan AK, Pillers DA. Redefinition of dystrophin
isoform distribution in mouse tissue by RTPCR
implies role in nonmuscle manifestations
of duchenne muscular dystrophy. Mol Genet
Metab. 1998; 65(4): 272-281.
8. Anderson JL, Head SI, Rae C, Morley JW. Brain
function in Duchenne muscular dystrophy. Brain.
2002; 125(1): 4-13.
9. Perronnet C, Vaillend C. Dystrophins, utrophins,
and associated scaffolding complexes: Role in
mammalian brain and implications for therapeutic
strategies. J Biomed Biotechnol. 2010; 2010:
849426. doi: 10.1155/2010/ 849426.
10. Pillers DA, Bulman DE, Weleber RG, Sigesmund
DA, Musarella MA, Powell BR, et al.
Dystrophin expression in the human retina is
required for normal function as defined by electroretinography.
Nat Genet. 1993; 4(1): 82-86.
11. Lidov HG, Selig S, Kunkel LM. Dp140: A novel
140 kDa CNS transcript from the dystrophin
locus. Hum Mol Genet. 1995; 4(3): 329-335.
12. Byers TJ, Lidov HG, Kunkel LM. An alternative
dystrophin transcript specific to peripheral nerve.
Nat Genet. 1993; 4(1): 77-81.
13. Bar S, Barnea E, Levy Z, Neuman S, Yaffe D,
Nudel U. A novel product of the Duchenne muscular
dystrophy gene which greatly differs from
the known isoforms in its structure and tissue
distribution. Biochem J. 1990; 272(2): 557-560.
14. Taylor PJ, Betts GA, Maroulis S, Gilissen C,
Pedersen RL, Mowat DR, et al. Dystrophin
gene mutation location and the risk of cognitive
impairment in Duchenne muscular dystrophy.
PLoS One. 2010; 5(1): e8803. doi: 10.1371/
journal.pone.0008803.
15. Daoud F, Angeard N, Demerre B, Martie I,
Benyaou R, Leturcq F, et al. Analysis of Dp71
contribution in the severity of mental retardation
through comparison of Duchenne and Becker
patients differing by mutation consequences
on Dp71 expression. Hum Mol Genet. 2009;
18(20): 3779-3794.
16. Tozawa T, Itoh K, Yaoi T, Tando S, Umekage M,
Dai H, et al. The shortest isoform of dystrophin
(Dp40) interacts with a group of presynaptic
proteins to form a presumptive novel complex
in the mouse brain. Mol Neu-robiol. 2012; 45(2):
287-297.
17. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg
D, Diepvens F, Pals G. Relative quantification
of 40 nucleic acid sequences by multiplex ligationdependent
probe amplification. Nucleic Acids Res.
2002; 30(12): e57. doi: 10.1093/nar/gnf056.
18. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen
PN, Caskey CT. Deletion screening of the Duchenne
muscular dystrophy locus via multiplex
DNA amplification. Nucleic Acids Res. 1988;
16(23): 11141-11156.
19. Beggs AH, Koenig M, Boyce FM, Kunkel LM.
Detection of 98% of DMD/BMD gene deletions
by polymerase chain reaction. Hum Genet. 1990;
86(1): 45-48.
20. Kunkel LM, Snyder JR, Beggs AH, Boyce FM,
Feener CA. Searching for dystrophin gene deletions
in patients with atypical presentations.
In: Lindsten J, Petterson U, Eds. Etiology of
Human Diseases at the DNA Level. New York,
NY: Raven Press. 1991: 51-61.
21. Den Dunnen JT, Antonarakis SE. Mutation nomenclature
extensions and suggestions to describe
complex mutations: A discussion. Hum
Mutat. 2000; 15(1): 7-12.
22. Bushby KM, Appleton R, Anderson LV, Welch
JL, Kelly P, Gardner-Medwin D. Deletion status
and intellectual impairment in Duchenne muscular
dystrophy. Dev Med Child Neurol. 1995;
37(3): 260-269.
23. Desguerre I, Christov C, Mayer M, Zeller R, Becane
HM, Bastuji-Garin S, et al. Clinical heterogeneity
of Duchenne Muscular Dystrophy (DMD):
Definition of sub-phenotypes and predictive criteria
by long-term follow-up. PLoS One. 2009;
4(2): e4347. doi: 10.1371/ ournal.pone.0004347.
24. Wechsler D. Manual for the Wechsler Intelligence
Scale for Children, 3rd ed. New York,
NY: Psychological Corporation, 1991.
25. Brunet O, Lezine PUF. Le Developpement Psychologique
del al Premiere Enfance. Issy-les-
Moulineaux. France: Editions Scientifiques et
Psychotechniques, 1951.
26. Doll EA. Vineland Social Maturity Scale. Oxford,
UK: Educational Test Bureau, 1947.
27. Hinton VJ, Fee RJ, Goldstein EM, De Vivo
DC. Verbal and memory skills in males with
Duchenne muscular dystrophy. Dev Med Child
Neurol. 2007; 49(2): 123-128.
28. D’Angelo MG, Lorusso ML, Civati F, Comi
GP, Magri F, Del Bo R, et al. Neurocognitive
profiles in Duchenne muscular dystrophy and
gene mutation site. Pediatr Neurol. 2011; 45(5):
292-299.
29. Wingeier K, Giger E, Strozzi S, Kreis R, Joncourt
F, Conrad B, et al. Neuropsychological impairments
and the impact of dystrophin mutations
on general cognitive functioning of patients with
Duchenne muscular dystrophy. J Clin Neurosci.
2011; 18(1): 90-95.
30. Lorusso ML, Civati F, Molteni M, Turconi AC,
Bresolin N, D’Angelo MG. Specific profiles of
neurocognitive and reading functions in a sample
of 42 Italian boys with Duchenne Muscular
Dystrophy. Child Neuropsychol. 2013; 19(4):
350-369.
31. Chamova T, Guergueltcheva V, Raycheva M,
Todorov T, Genova F, Bichev S, et al. Association
between loss of Dp140 and cognitive impairment
in Du-henne and Becker dystrophies.
Balkan J Med Genet. 2013; 16(1): 21-30.
32. Knuesel I, Bornhauser BC, Zuellig RA, Heller F,
Schaub MC, Fritschy JM. Differential expression
of utrophin and dystrophin in CNS neurons: An
in situ hybridization and immunohistochemical
study. J Comp Neurol. 2000; 422(4): 594-611.
33. Sekiguchi M, Zushida K, Yoshida M, Maekawa
M, Kamichi S, Yoshida M, et al. A deficit of
brain dystrophin impairs specific amygdala GABAergic
transmission and enhances defensive
behaviour in mice. Brain. 2009; 132(1): 124-135.
34. Moizard MP, Toutain A, Fournier D, Berret F,
Raynaud M, Billard C, et al. Severe cognitive
impairment in DMD: Obvious clinical indication
for Dp71 isoform point mutation screening. Eur
J Hum Genet. 2000; 8(7): 552-556.
35. Moizard MP, Billard C, Toutain A, Berret F,
Marmin N, Moraine C. Are Dp71 and Dp140
brain dystrophin isoforms related to cognitive
impairment in Duchenne muscular dystrophy?
Am J Med Genet. 1998; 80(1): 32-41.
36. Chelly J, Khelfaoui M, Francis F, Cherif B, Bienvenu
T. Genetics and pathophysiology of mental
retardation. Eur J Hum Genet. 2006; 14(6): 701-713.
37. Felisari G, Martinelli Boneschi F, Bardoni A,
Sironi M, Comi GP, Robotti M, et al. Loss of
Dp140 dystrophin isoform and intellectual impairment
in Duchenne dystrophy. Neurology.
2000; 55(4): 559-564.
38. Haenggi T, Soontornmalai A, Schaub MC, Fritschy
JM. The role of utrophin and Dp71 for assembly
of different dystrophin-associated protein
complexes (DPCs) in the choroid plexus
and microvasculature of the brain. Neuroscience.
2004; 129(2): 403-413.
39. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell
KP. Identification and characterization of the
dystrophin anchoring site on β-dystroglycan. J
Biol Chem. 1995; 270(45): 27305-27310.
40. Sigelman C, Rider EA. Life-Span Human Development,
7th ed. Belmont, CA: Wadsworth
Cengage Learning, 2012.
41. Wu JY, Kuban KC, Allred E, Shapiro F, Darras
BT. Association of Duchenne muscular dystrophy
with autism spectrum disorder. J Child
Neurol. 2005; 20(10): 790-795.
42. Ferlini A, Neri M, Gualandi F. The medical genetics
of dystrophinopathies: Molecular genetic
diagnosis and its impact on clinical practice.
Neuromusc Disord. 2013; 23(1): 4-14.
|
|
|
|
 |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
